Malignant Urinary Tract Neoplasm — Trials

Malignant Urinary Tract Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,955 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 507
Recruiting: 271
Ph III recruiting: 36
Growth YoY: +23.2%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (246)

clinicaltrialsPublishedShowing 251–300 of 666 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03768570	Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer	active not recruiting	Phase 2	82	Canadian Cancer Trials GroupNETWORK	3	Jun 18, 2026	clinicaltrials
NCT06257264	A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors	active not recruiting	Phase 1	103	BeiGeneINDUSTRY	6	Jun 18, 2026	clinicaltrials